Corteva (CTVA)

Materials · $8.1B market cap · SEC CIK 0001755672

Next reports on Nov 11, 2026, after the close, with analysts expecting $0.10 in earnings per share.

52-week range $11.25 to $90.97. 87% below its 52-week high and 8% above its low.

The case for CTVA

• Cheap for its growth: 7.9× mid-cycle earnings, where 7% a year of growth plus a 1.4% dividend would justify about 20×.
• Generated $2.8B of free cash flow in FY2025, 16% of revenue.
• Holds more cash ($4.5B) than long-term debt ($1.7B).
• Free cash flow of 34.7% of its market value a year: a lot of cash for the price.
• Moves less than the market (beta 0.69).
• Pays a modest 1.4% dividend.

The case against

• Down 81.1% over the past year.
• Return on equity of only 4%.
• Near the bottom of its 52-week range, 87% below the high. Falling prices usually have a reason; find it first.

What the score is made of

Each factor is half a curve over reported figures and half a rank among the other Materials companies (momentum is judged against fixed thresholds only), and the five are blended by weight. The score is where that blend places it in the S&P 500. It describes the last filing and the current price. It is not a forecast.

• Its profits follow commodity prices, so its earnings and margin are read as half the latest year and half the average of the years on file (5), and last year's change in earnings per share is not counted as growth.
• Each factor except momentum is half fixed thresholds, half rank among the 26 Materials companies.

The financials

The financials, five years deep

Pulled from Corteva's XBRL filings on SEC EDGAR. Italic rows are worked out from the others.

What Corteva says it does

Unless otherwise indicated or the context otherwise requires, references in this Annual Report on Form 10-K to: • "Corteva" or "the company" refers to Corteva, Inc. and its consolidated subsidiaries (including EIDP); • "EIDP" refers to EIDP, Inc. (formerly known as E. I. du Pont de Nemours and Company) and its consolidated subsidiaries or EIDP, Inc. excluding its consolidated subsidiaries, as the context may indicate; • "DowDuPont" refers to DowDuPont Inc. and its subsidiaries prior to the Corteva Separation (as defined below); • "Historical Dow" refers to The Dow Chemical Company and its consolidated subsidiaries prior to the Internal Reorganization (as defined in Note 1 - Background and Basis of Presentation, to the Consolidated Financial Statements); • "Historical DuPont" and "Historical EID" refers to EIDP prior to the Internal Reorganization; • "Dow" refers to Dow Inc. after its separation from DowDuPont; • "DuPont" refers to…

Risk factors CTVA lists in its 10-K

• Corteva may not be able to obtain or maintain the necessary regulatory approvals for some of its products, including its seed and crop protection products, which could restrict its ability to sell those products in some markets
• The successful development and commercialization of Corteva's pipeline products will be necessary for Corteva's growth
• Changes in agricultural and related policies of governments and international organizations may prove unfavorable
• Climate change and unpredictable seasonal and weather factors could impact Corteva’s sales and earnings
• Corteva participates in an industry that is highly competitive and has undergone consolidation, which could increase competitive pressures
• Recent funding and staff reductions, including at the EPA, the USDA, the FDA and the U.S. Department of Health and Human Services ("HHS"), could hinder our ability to receive timely regulatory approvals
• Corteva’s sales to its customers may be adversely affected should a company successfully establish an intermediary platform for the sale of Corteva’s products or otherwise position itself between Corteva and its customers
• Our business, financial condition and results of operations could be materially affected by disruptions in the global economy caused by geopolitical and military conflicts
• Volatility in Corteva’s input costs, which include raw materials and production costs, could have a significant impact on Corteva’s business, results of operations and financial condition
• Corteva’s operations outside the United States are subject to risks and restrictions, which could negatively affect Corteva’s business, results of operations and financial condition
• Corteva’s business, results of operations and financial condition could be adversely affected by industrial espionage and other disruptions to its supply chain, information technology or network systems
• Corteva is dependent on its relationships or contracts with third parties with respect to certain of its raw materials or licenses and commercialization
• Corteva’s customers may be unable to pay their debts to Corteva, which could adversely affect Corteva’s results
• Failure to effectively manage acquisitions, divestitures, strategic investments, restructurings, cost savings initiatives and other portfolio actions may not have the results anticipated
• Corteva’s liquidity, business, results of operations and financial condition could be impaired if it is unable to raise capital through the capital markets or short-term debt borrowings
• Increases in pension and other post-employment benefit plan funding obligations may adversely affect Corteva’s results of operations, liquidity or financial condition
• Global or regional health pandemics or epidemics could negatively impact the company's business, financial condition and results of operations
• Sentiment towards sustainability matters could adversely affect our stock price, results of operations, and access to capital
• Enforcing Corteva’s intellectual property rights, or defending against intellectual property claims asserted by others, could materially affect Corteva’s business, results of operations and financial condition
• Corteva’s business may be adversely affected by the availability of counterfeit products
• Restrictions under the intellectual property cross-license agreements limit Corteva’s ability to develop and commercialize certain products and services and/or prosecute, maintain and enforce certain intellectual property
• The Corteva Separation and related transactions may expose Corteva to potential liabilities arising out of state and federal fraudulent conveyance laws
• The company is subject to continuing contingent tax-related liabilities of DowDuPont following the Distribution

Filings

Other Materials companies